51 years Male (DOB:5/6/1964)Reason: For Research: GBM s/p resection with Ziopharm trial. eval changes in tumor History: surveillancePROVIDER/ATTENDING NAME: BAKHTIAR YAMINI BAKHTIAR YAMINI The patient status post left-sided craniotomy and left temporal lobe surgery. There is redemonstration of an enhancing mass centered in the left temporal lobe and surrounding the temporal horn of the left lateral ventricle. It is irregularly shaped enhances heterogeneously and has heterogeneous signal on T2 imaging. It is associated vasogenic edema extending to the left parietal lobe and occipital lobe and multiple foci of susceptibility within the enhancing component of the lesion which are compatible with microhemorrhages. The enhancing component measures 46 x 29 mm axial dimensions and previously measured 29 x 46 mm axial dimensions. There is an enhancing tract extending from the surface of the left temporal lobe into the lesion which was also present on the prior exam. Overall this has not significantly changed compared to prior exam.There is redemonstration of mild uncal herniationNormal vascular flow voids are present in the distal carotid and vertebral arteries, the basilar artery and the proximal anterior, middle and posterior cerebral arteries as well as the internal cerebral veins and superior sagittal sinus.The visualized portions of the paranasal sinuses demonstrate mucosal thickening and status post paranasal sinus surgery.. The visualized portions of the mastoid air cells demonstrate minor opacities The visualized portions of the orbits are intact.
Since the prior exam from 4/20/2016 there has been no significant interval change in the patients left temporal lobe mass surrounding the temporal horn of the left lateral ventricle.